Publication of Suppl.Prospcts

RNS Number : 7404J
Nationwide Building Society
14 December 2022
 

RNS ANNOUNCEMENT

 

NATIONWIDE BUILDING SOCIETY

€45,000,000,000 GLOBAL COVERED BOND PROGRAMME

 

14 December 2022

 

Publication of Supplement

 

The following supplement dated 14 December 2022 (the Supplement) produced in connection with the €45,000,000,000 Global Covered Bond Programme (the Programme) established by Nationwide Building Society, has been approved by the Financial Conduct Authority and is available for viewing:

 

Supplement dated 14 December 2022, supplemental to the Prospectus dated 2 September 2022, as supplemented by the first supplement dated 18 November 2022 prepared in connection with the €45,000,000,000 Global Covered Bond Programme established by Nationwide Building Society.

 

To view the full document, please paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/7404J_1-2022-12-14.pdf

 

A copy of the above document will also be submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

For further information, please contact

 

Sarah Abercrombie

Head of Investor Relations and Credit Ratings

 

Mobile: +44 (0) 7587 886 500

Email:   Sarah.Abercrombie@nationwide.co.uk

 

Michael Constantine

Head of Treasury Legal

 

Mobile: +44 (0) 7500 088 406

E-mail:  Michael.Constantine@nationwide.co.uk

 

Nationwide Building Society

Nationwide House

Pipers Way

Swindon

SN38 1NW

 

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Base Prospectus, as supplemented by the Supplement, may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus, as so supplemented, is not addressed. Prior to relying on the information contained in the Base Prospectus, as so supplemented, you must ascertain from the Base Prospectus, as so supplemented, whether or not you are part of the intended addressees of the information contained therein.

In particular, the Base Prospectus, as supplemented by the Supplement, does not constitute an offer of securities for sale in the United States. Neither the Base Prospectus nor the Supplement are for distribution in the United States. The securities described therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States.

 

Your right to access this service is conditional upon complying with the above requirement. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPFLFLEFRLSLIF
UK 100

Latest directors dealings